Clearance of C4d deposition after successful treatment of acute humoral rejection in follow-up biopsies: A report of three cases

Transplant International

Volumn 17, Issue 4, 2004, Pages 177-181

  Koller, Hendrik ^a   Steurer, Wolfgang ^a   Mark, Walter ^a   Margreiter, Raimund ^a   Lhotta, Karl ^a   Mayer, Gert ^a   Rosenkranz, Alexander R ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Acute rejection; C4d; Humoral rejection; Immunoadsorption; Plasmapheresis; Transplantation

Indexed keywords

ALLOPURINOL; AZATHIOPRINE; CALCINEURIN INHIBITOR; COMPLEMENT COMPONENT C4D; CYCLOSPORIN; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ACUTE HUMORAL REJECTION; ADULT; ANTIGEN ANTIBODY REACTION; ARTICLE; CASE REPORT; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; DISEASE COURSE; DISEASE MARKER; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOADSORPTION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; BIOPSY; COMPLEMENT C4B; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSORBENT TECHNIQUES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PLASMAPHERESIS;

EID: 2942588728     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00147-004-0699-2     Document Type: Article

References (19)

1. Racusen LC, Solez K, Colvin RB, et al. Antibody-mediated rejection criteria and biopsy classification - an addition to the Banff '97 classification. Am J Transplant 2003; 3:708.
2. Aichberger C, Nussbaumer W, Rosmanith P, et al. Plasmapheresis for the treatment of acute vascular rejection in renal transplantation. Transplant Proc 1997; 29:169.
3. Bohmig GA, Regele H, Exner M, et al. C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. J Am Soc Nephrol 2001; 12:2482.
4. Jordan SC, Quartel AW, Czer LS, et al. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 1998; 66:800.
5. Mastrangelo F, Pretagostini R, Berloco P, et al. Immunoadsorption with protein A in humoral acute rejection of kidney transplants: multicenter experience. Transplant Proc 1995; 27:892.
6. Montgomery RA, Zachary AA, Racusen LC, et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000; 70:887.
7. Pascual M, Saidman S, Tolkoff-Rubin N, et al. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation 1998; 66:1460.
8. Persson NH, Bucin D, Ekberg H, et al. Immunoadsorption in acute vascular rejection after renal transplantation. Transplant Proc 1995; 27:3466.
9. Collins AB, Schneeberger EE, Pascual MA, et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10:2208.
10. Crespo M, Pascual M, Tolkoff-Rubin N, et al. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 2001; 71:652.
11. Herzenberg AM, Gill JS, Djurdjev O, et al. C4d deposition in acute rejection: an independent long-term prognostic factor. J Am Soc Nephrol 2002; 13:234.
12. Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13:779.
13. Barba LM, Caldwell PR, Downie GH, et al. Lung injury mediated by antibodies to endothelium. I. In the rabbit a repeated interaction of heterologous anti-angiotensin-converting enzyme antibodies with alveolar endothelium results in resistance to immune injury through antigenic modulation. J Exp Med 1983; 158:2141.
14. Brentjens JR, Andres G. Interaction of antibodies with renal cell surface antigens. Kidney Int 1989; 35:954.
15. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55:713.
16. Trpkov K, Campbell P, Pazderka F, et al. Pathologic features of acute renal allograft rejection associated with donor-specific antibody, analysis using the Banff grading schema. Transplantation 1996; 61:1586.
17. Madan AK, Slakey DP, Becker A, et al. Treatment of antibody-mediated accelerated rejection using plasmapheresis. J Clin Apheresis 2000; 15:180.
18. Higgins RM, Bevan DJ, Carey BS, et al. Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation. Lancet 1996; 348:1208-1211.
19. Schroeder TJ, Weiss MA, Smith RD, et al. The efficacy of OKT3 in vascular rejection. Transplantation 1991; 51:312.